Abstract. In this study, we investigated the immunoreactivity of vascular endothelial growth factor (VEGF) and its receptors flt-1 (VEGFR1) and the kinase domain receptor (KDR/Flk-1, VEGFR2) in the uteri of the wild ground squirrels during the estrous period, early pregnancy and nonbreeding period. Cellular localizations of VEGF, VEGFR1 and VEGFR2 were detected by immunohistochemistry, and total proteins were extracted from uterine tissue in the estrous period, early pregnancy and nonbreeding period for Western blotting analysis. In addition, plasma estradiol-17β and progesterone concentrations were measured by radioimmunoassay. Stronger positive staining of VEGF was found in luminal epithelial cells and glandular cells, and its receptors (VEGFR1 and VEGFR2) were observed in stromal cells in the estrous period and early pregnancy compared with the nonbreeding period. The protein levels of VEGF, VEGFR1 and VEGFR2 were significantly higher in the estrous period and early pregnancy as compared with the nonbreeding period. Besides, plasma estradiol-17β and progesterone concentrations were higher in the estrous period and early pregnancy than in the nonbreeding period, suggesting that the immunoreactivities of VEGF, VEGFR1 and VEGFR2 were correlated with changes in plasma estradiol-17β and progesterone concentrations. These results suggested that VEGF and its receptors may be involved in the regulation of seasonal changes in the uterine functions of wild female ground squirrels. Key words: Uterus, VEGF, VEGFR1, VEGFR2, Wild ground squirrel (J. Reprod. Dev. 58: [537][538][539][540][541][542][543] 2012) D uring the reproductive cycle, the uterine endometrium undergoes a precisely timed complex sequence of physiological and morphological changes in preparation for implantation. These changes are controlled primarily by the ovarian steroid hormones 17β-estradiol (E 2 ) and progesterone [1]. During pregnancy, blood flow to the uterus is increased dramatically to meet the rising demands of the growing fetus. Endocrine control of this phenomenon is complex but includes in part the action of many growth factors [2,3]. Vascular endothelial growth factor (VEGF) is a protein with angiogenic activity and a potent stimulator of microvascular permeability [4,5]. It plays an important role in physiological and pathological neovascularization via its receptors Flt1/VEGFR1 and kinase insert domain containing region (KDR)/VEGFR2, both of which have tyrosine kinase activity [6]. In reproductive organs, VEGF is required for normal ovarian angiogenesis and endometrial growth throughout the ovulatory cycle in humans [7,8] and rodents [9,10]. The expression of VEGF and its receptors has been demonstrated in the endometrium in humans and in experimental and domestic animals throughout the menstrual cycle, with an upregulation in the late proliferative and luteal phases [11][12][13][14][15], periods that correspond to angiogenesis and an increase in vascular permeability [16]. However, the expression of VEGF and its receptors VEGFR1 and V...